非HIV感染者隐球菌性脑膜炎PIIRS激素减量治疗的长期结局
该前瞻性观察研究纳入15例免疫正常的隐球菌性脑膜炎后感染性炎症综合征(PIIRS)成人,采用脉冲式糖皮质激素减量(PCT)方案治疗。一年后体能状态持续改善,神经认知仅存轻微残留缺陷,眼部异常显著持续减少,视野缺损改善40%后稳定,听力变化不一,影像学异常79%改善。结论认为辅助激素治疗与神经、视觉和影像学结局的持续改善相关。
要点
- 免疫正常CM-PIIRS患者经PCT治疗后一年神经、视觉及影像学结局持续改善。
- 听力改善证据不一,44.5%耳改善、11%恶化、44.5%稳定。
- MRI可用于评估减量反应,延长激素减量可能有益。
核心结论
- 在免疫正常的CM-PIIRS患者中,辅助糖皮质激素治疗与一年后神经、视觉和影像学结局的持续改善相关,听力改善不一,并遗留轻微缺陷。
研究设计与样本
- 前瞻性观察研究,纳入15例免疫正常成人CM-PIIRS患者,接受脉冲式糖皮质激素减量(PCT)方案。
- 在CM诊断后大于一年时进行体能状态、神经认知、眼科、听力和影像学评估。
主要发现
- 一年后体能状态较基线和脉冲后时期持续改善。
- 神经认知测试显示轻微残留缺陷,在正常范围内,以信息处理和精神运动速度最突出。
- 眼部异常在基线常见,PCT后显著且持续减少,尤其是视网膜神经纤维层厚度。
- 视野缺损改善40%并此后保持稳定。
- 影像学异常在79%患者中改善,PCT期间出现间歇性炎症 flare 但对剂量增加有反应。
关键数值与推荐
- 听力变化证据不一:44.5%的耳符合改善标准,11%符合恶化标准,44.5%保持稳定。
- 视野缺损改善40%。
- 影像学异常改善者占79%。
临床怎么用
- 对免疫正常CM-PIIRS患者可考虑辅助脉冲式糖皮质激素减量治疗。
- 延长激素减量可能有益,MRI可用于评估减量反应。
- 治疗期间需监测间歇性炎症 flare,必要时增加剂量。
局限性
- 样本量小(15例),为观察性研究,无对照组。
- 听力结局证据不一,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Post-infectious inflammatory response syndrome (PIIRS) is an increasingly recognized complication of cryptococcal meningoencephalitis (CM) in non-HIV infected hosts with significant morbidity and mortality. Data describing long-term outcomes following immunomodulatory therapy are limited. METHODS: We conducted a prospective observational study of 15 immunocompetent adults with CM-PIIRS treated with a pulse corticosteroid taper (PCT) regimen. Performance status, neurocognitive, ophthalmologic, audiologic, and radiologic assessments were performed at greater than one year following CM diagnosis. RESULTS: After one year, performance status continued to improve from both baseline and the post-pulse periods. Neurocognitive testing revealed mild residual deficits, within the limits of normal, most prominently in information processing and psychomotor speed. Ocular abnormalities were frequent at baseline but showed substantial and sustained reductions following PCT, particularly in retinal nerve fiber layer thickness. Visual field deficits improved by 40% and remained stable thereafter. Evidence for changes in hearing sensitivity at post 1-year follow-up was mixed with 44.5% of ears meeting criteria for improvement, 11% for worsening, and 44.5% being stable. Radiologic abnormalities improved in 79% of patients, although intermittent inflammatory flares occurred during PCT but responded to dose escalation. A prolonged corticosteroid taper may be helpful, and MRI imaging can be used to evaluate response to taper. CONCLUSIONS: In immunocompetent patients with CM-PIIRS, adjunctive corticosteroid therapy was associated with sustained improvement in neurologic, visual, and radiologic outcomes with mixed improvement in hearing after a year of therapy, with mild residual deficits.
引用
- Chang BH, Hargarten JC, Ssebambulidde K, et al. Long-term Outcomes in Previously Healthy non-HIV Individuals with Cryptococcal Meningitis Treated with Pulse-taper Corticosteroids for Post-infectious Inflammatory Syndrome. J Infect Dis. 2026. PMID: 42862893. doi:10.1093/infdis/jiag511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。